Biodistribution and individual dosimetry of I-131-labeled Rituximab in relapsed non-Hodgkin's lymphoma

被引：0
|
作者：
Scheidhauer, K
Wolf, I
von Schilling, C
Schmidt, B
Baumgartl, H
Reidel, G
Peschel, C
Schwaiger, M
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, D-8000 Munich, Germany
[2] Tech Univ Munich, Med Klin 3, D-8000 Munich, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 2001年 / 28卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OS79
引用
收藏
页码：981 / 981
页数：1
相关论文
共 50 条
  • [41] Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma
    Kang, Hye Jin
    Lee, Seung-Sook
    Byun, Byung Hyun
    Kim, Kyeong Min
    Lim, Ilhan
    Choi, Chang Woon
    Suh, Cheolwon
    Kim, Won Seog
    Nam, Seung-Hyun
    Lee, Soon Il
    Eom, Hyeon Seok
    Shin, Dong-Yeop
    Lim, Sang Moo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 945 - 953
  • [42] Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial
    Kambhampati, Swetha
    Fakhri, Bita
    Ai, Weiyun Z.
    Kaplan, Lawrence D.
    Tuscano, Joseph M.
    Wieduwilt, Matthew J.
    Sudhindra, Akshay
    Cavallone, Erika
    Reiner, Jesika
    Aoun, Charlie
    Castillo, Miguel
    Martinelli, Michelle
    Ta, Teresa
    Le, Diem
    Padilla, Michelle
    Crawford, Erika
    Andreadis, Charalambos B.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (03): : 139 - 146
  • [43] Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma
    Hye Jin Kang
    Seung-Sook Lee
    Byung Hyun Byun
    Kyeong Min Kim
    Ilhan Lim
    Chang Woon Choi
    Cheolwon Suh
    Won Seog Kim
    Seung-Hyun Nam
    Soon Il Lee
    Hyeon Seok Eom
    Dong-Yeop Shin
    Sang Moo Lim
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 945 - 953
  • [44] 131I-Tositumomab (Bexxar®) Therapy of Refractory/Relapsed Non-Hodgkin Lymphoma: Clinical Experience
    Iagaru, A.
    Knox, S.
    Goris, M. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S148 - S149
  • [45] 67Cu- versus 131I-labeled Lym-1 antibody:: Comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma
    DeNardo, GL
    Kukis, DL
    Shen, S
    DeNardo, DA
    Meares, CF
    DeNardo, SJ
    CLINICAL CANCER RESEARCH, 1999, 5 (03) : 533 - 541
  • [46] Fractionated radioimmunotherapy (RIT) with iodine 131 labelled rituximab is feasibel and efficacious in relapsed low grade non-Hodgkin lymphoma
    Ilidge, T
    Bayne, M
    Zivanovic, M
    Mead, B
    Johnson, P
    ANNALS OF ONCOLOGY, 2005, 16 : 111 - 112
  • [47] Refractoriness to rituximab monotherapy in a child with relapsed/refractory Burkitt non-Hodgkin lymphoma
    Okur, FV
    Oguz, A
    Karadeniz, C
    Citak, C
    Poyraz, A
    Boyunaga, O
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2006, 23 (01) : 25 - 31
  • [48] Treatment procedure for iodine-131Labeled antibody for Non-Hodgkin's lymphoma (NHL)
    Nair, M
    Anderson, P
    Neumann, T
    Mark, R
    MEDICAL PHYSICS, 2004, 31 (06) : 1925 - 1925
  • [49] Repeated radioimmunotherapy (RIT) with 131I-rituximab for patients with low grade and aggressive relapsed/refractory B-cell non-Hodgkin's lymphoma (NHL)
    Kang, Hye Jin
    Lee, Seung-Sook
    Kim, Kyeong Min
    Lim, Sang Moo
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [50] Investigation of change in residence-time in repeated radioimmunotherapy using I-131 rituximab for non-hodgkin's lymphoma
    Lim, S.
    Park, J.
    Kim, K.
    Kang, H.
    Choi, T.
    Kim, J.
    Woo, S.
    Kim, J.
    Kim, B.
    Cheon, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S292 - S292
12345